Hendri H. Pas

Hendri H. Pas

Auto-generated profile, based on publicly available information

Hendri H. Pas

Department of Dermatology, Expertise Center for Blistering Diseases University of Groningen, University Medical Center Groningen Groningen the Netherlands

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1997 in Cell
Verified
Journal Article
Closed access
MJMarcel F Jonkman
Marcel F Jonkman
HSHans Scheffer
Hans Scheffer
RSRein Stulp
Rein Stulp
HPHendri H Pas
Hendri H Pas
MNMiranda Nijenhuis
Miranda Nijenhuis
JUJouni Uitto
Jouni Uitto

1 October 2005 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MJMarcel F. Jonkman
Marcel F. Jonkman
APAnna M.G. Pasmooij
Anna M.G. Pasmooij
SPSuzanne G.M.A. Pasmans
Suzanne G.M.A. Pasmans
MBMaarten P. van Den Berg
Maarten P. van Den Berg
HHHenk J. ter Horst
Henk J. ter Horst
HPHendri H. Pas
Hendri H. Pas

1 July 2004 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
RVR.M. Vodegel
R.M. Vodegel
MJM.F. Jonkman
M.F. Jonkman
HPH.H. Pas
H.H. Pas
MJM.C.J.M. De Jong
M.C.J.M. De Jong

1 March 1995 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MJM F Jonkman
M F Jonkman
MJM C de Jong
M C de Jong
KHK Heeres
K Heeres
HPH H Pas
H H Pas
JMJ B van der Meer
J B van der Meer
ASA Sonnenberg
A Sonnenberg
Generalized atrophic benign epidermolysis bullosa (GABEB) is a form of nonlethal junctional epidermolysis bullosa characterized by universal alopecia and atrophy of the skin. We report a deficiency of the 180-kD bullous pemphigoid antigen in three patients with GABEB from unrelated families. We screened specimens of clinically normal skin from nine junctional epidermolysis bullosa patients (3 GABEB, 4 lethal, 1 cicatricial, 1 pretibial) by immunofluorescence using monoclonal antibodies to the 180-kD and 230-kD bullous pemphigoid antigens (BP180 and BP230). In the skin of the three GABEB patients there was no reactivity with antibodies to BP180, whereas staining for BP230 was normal. In the skin of the other six, non-GABEB patients, included in this study the expression of BP180 and BP230 was normal. Immunoblot analysis of cultured keratinocytes from one of the GABEB patients also failed to detect BP180 antigen, whereas BP230 was present in normal amounts. The deficient expression of BP180 is reflected in the RNA message, as in Northern blot analysis a reduced amount of BP180 transcripts, although of normal length, were detected. Interestingly, in another GABEB patient there were not-involved areas of skin, in which blistering could not be induced by rubbing. Biopsy material from these areas showed interrupted staining for BP180. There was no staining for BP180 in areas of clinically normal but involved skin of this patient. In conclusion, this study reveals that the BP180 antigen is deficient and the BP180 mRNA is reduced in generalized atrophic benign epidermolysis bullosa.

1 April 1997 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
HPHendri H. Pas
Hendri H. Pas
GKGuus J. Kloosterhuis
Guus J. Kloosterhuis
KHKlaas Heeres
Klaas Heeres
JMJan B. Van der Meer
Jan B. Van der Meer
MJMarcel F. Jonkman
Marcel F. Jonkman

1 November 1996 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
MJMarcel F. Jonkman
Marcel F. Jonkman
KHKlaas Heeres
Klaas Heeres
HPHendri H. Pas
Hendri H. Pas
MLMarja J.A. van Luyn
Marja J.A. van Luyn
JEJob D. Elema
Job D. Elema
HSHans Scheffer
Hans Scheffer